MODERN HEMATOLOGY SECOND EDITION



Similar documents
Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

Introduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

A Career in Pediatric Hematology-Oncology? Think About It...

Malignant Lymphomas and Plasma Cell Myeloma

Adult Medical-Surgical Nursing H A E M A T O L O G Y M O D U L E : L E U K A E M I A 2

Leukemias and Lymphomas: A primer

Stem Cell Transplantation

BONE MARROW FAILURE DISEASE SYMPOSIUM SATURDAY SEPTEMBER 27, 2014 AN UPDATE ON THE LATEST IN DIAGNOSIS AND TREATMENT

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart

Corporate Medical Policy

Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT

Acute myeloid leukemia (AML)

Oncology Best Practice Documentation

Acute Myeloid Leukemia

MEDICAL COVERAGE POLICY

Lauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?

Cord Blood Stem Cell Transplantation

Acute myeloid leukaemia (AML) in children

Interesting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA

GRANIX (tbo-filgrastim)

Mayo Clinic College of Medicine Pharmacy Services. Rotation Summary

4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

Daiichi Sankyo to Acquire Ambit Biosciences

Hematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine

»medical programs and services. transfusion medicine fellowship program

2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders

Haematopoietic Chimerism Analysis after Allogeneic Stem Cell Transplantation

The Treatment of Leukemia

Cord blood Banking Transplant List for One USA Bank - StemCyte

Houston Cancer Institute

5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

Careers in Haematology

ACUTE MYELOID LEUKEMIA (AML),

Hematology Morphology Critique

STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA

»medical programs and services. transfusion medicine fellowship program

What we will discuss today

Cord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD

An overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham

PT CordLife Indonesia Premium Cordblood Bank. PT CordLife Indonesia Premium Cordblood Bank

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide

Stem Cell Transplantation and the Canadian First Nations Community. Becky Luk (PTLS) Tanya Petraszko, MD

Cord Blood: Research Progress and Future Promise

3 PART ONE: The Principles of Hematology PART TWO: Erythrocytes 89 5

PROGNOSIS IN ACUTE LYMPHOBLASTIC LEUKEMIA PROGNOSIS IN ACUTE MYELOID LEUKEMIA

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I RESPONSE ASSESSMENT LEUKEMIA CHAPTER 11A REVISED: OCTOBER 2015

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood

House Resolution No. 37

INSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Corporate Medical Policy Genetic Testing for Fanconi Anemia

Program Co-Chairmen: Dr. John Wagner, University of Minnesota Dr. Richard Champlin, M.D. Anderson Cancer Center

What is a Stem Cell Transplantation?

Things You Don t Want to Miss in Multiple Myeloma

CHAPTER 2. Neoplasms (C00-D49) March MVP Health Care, Inc.

Corporate Medical Policy

What is chronic lymphocytic leukaemia?

Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center

Blood and Marrow Stem Cell Transplantation

Clinical trials. Patient information. For anyone affected by blood cancer. bloodwise.org.uk

ST. VINCENT'S. MEDICAL CENTER St. Vincent's Healthcare

March 19, Dear Dr. Duvall, Dr. Hambrick, and Ms. Smith,

Exercise 9: Blood. Readings: Silverthorn 5 th ed, , ; 6 th ed, ,

From Immunotherapy of Cancer to the Discovery of Kidney Cancer Genes

BCSLS Telehealth Stem Cell Transplantation. Becky Luk, Patient & Transplant Liaison Specialist

guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research

Phone: Fax:

Not All Stem Cells are the Same

SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR.

cord blood saves lives...

The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant

Dr. Vivian Pijuan-Thompson (Cytology) (Cytology)

AREAS EMPLOYERS STRATEGIES/INFORMATION PHYSICAL THERAPY

My Sister s s Keeper. Science Background Talk

CAP Accreditation Checklists 2015 Edition

Cancer. 9p21.3 deletion. t(12;21) t(15;17)

Multiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options.

This presentation may contain forward-looking statements, which reflect Trillium's current expectation regarding future events. These forward-looking

Interesting Case Series. Periorbital Richter Syndrome

Chapter 4 Section High Dose Chemotherapy (HDC) And Stem Cell Transplantation

Summary of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Status

MANAGEMENT OF DATA IN CLINICAL TRIALS

Transcription:

MODERN HEMATOLOGY SECOND EDITION

CONTEMPORARY HEMATOLOGY Gary J. Schiller, MD, SERIES EDITOR Modern Hematology: Biology and Clinical Management, Second Edition, edited by REINHOLD MUNKER, ERHARD HILLER, JONATHAN GLASS, AND RONALD PAQUETTE, 2007 Stem Cell Transplantation for Hematologic Malignancies, edited by ROBERT J. SOIFFER, 2004 Biologic Therapy of Leukemia, edited by MATT KALAYCIO, 2003 Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management, by GUY B. FAGUET, 2003 Modern Hematology: Biology and Clinical Management, by REINHOLD MUNKER, ERHARD HILLER, AND RONALD PAQUETTE, 2000 Red Cell Transfusion: A Practical Guide, edited by MARION E. REID AND SANDRA J. NANCE, 1998

MODERN HEMATOLOGY Biology and Clinical Management, Second Edition Edited by REINHOLD MUNKER, MD Louisiana State University, Shreveport, LA ERHARD HILLER, MD Ludwigs-Maximilians Universität, Munich, Germany JONATHAN GLASS, MD Feist Weiller Cancer Center, Louisiana State University, Shreveport, LA RONALD PAQUETTE, MD University of California Los Angeles, Los Angeles, CA Foreword by H. PHILLIP KOEFFLER, MD Cedars-Sinai Medical Center, Los Angeles, CA

2007 Humana Press Inc. 999 Riverview Drive, Suite 208 Totowa, New Jersey 07512 humanapress.com For additional copies, pricing for bulk purchases, and/or information about other Humana titles, contact Humana at the above address or at any of the following numbers: Tel: 973-256-1699; Fax: 973-256-8341; E-mail: orders@humanapr.com; website at humanapress.com All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise without written permission from the Publisher. All articles, comments, opinions, conclusions, or recommendations are those of the author(s), and do not necessarily reflect the views of the publisher. Due diligence has been taken by the publishers, editors, and authors of this book to ensure the accuracy of the information published and to describe generally accepted practices. The contributors herein have carefully checked to ensure that the drug selections and dosages set forth in this text are accurate in accord with the standards accepted at the time of publication. Notwithstanding, as new research, changes in government regulations, and knowledge from clinical experience relating to drug therapy and drug reactions constantly occurs, the reader is advised to check the product information provided by the manufacturer of each drug for any change in dosages or for additional warnings and contraindications. This is of utmost importance when the recommended drug herein is a new or infrequently used drug. It is the responsibility of the health care provider to ascertain the Food and Drug Administration status of each drug or device used in their clinical practice. The publisher, editors, and authors are not responsible for errors or omissions or for any consequences from the application of the information presented in this book and make no warranty, express or implied, with respect to the contents in this publication. This publication is printed on acid-free paper. ANSI Z39.48-1984 (American National Standards Institute) Permanence of Paper for Printed Library Materials. Production Editor: Tracy Catanese Cover Illustration: Figure 3 from Chapter 9, Acute Myelogenous Leukemias by. Cover design by Patricia F. Cleary. Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Humana Press Inc., provided that the base fee of US $30.00 per copy is paid directly to the Copyright Clearance Center at 222 Rosewood Drive, Danvers, MA 01923. For those organizations that have been granted a photocopy license from the CCC, a separate system of payment has been arranged and is acceptable to Humana Press Inc. The fee code for users of the Transactional Reporting Service is: [978-1-58829-557-6 1-58829-557-5/07 $30.00]. Printed in the United States of America. 10 9 8 7 6 5 4 3 2 1 e-isbn-13: 978-1-59745-149-9 e-isbn-10: 1-59745-149-5 Library of Congress Cataloging-in-Publication Data Modern hematology : biology and clinical management / edited by... [et al.]. -- 2nd ed. p. ; cm. -- (Contemporary hematology) Rev. ed. of: Modern hematology /, Erhard Hiller, Ronald Paquette. c2000. Includes bibliographical references and index. ISBN-13: 978-1-58829-557-6 (alk. paper); ISBN-10: 1-58829-557-5 (alk. paper) 1. Blood--Diseases. 2. Hematology. I. Munker, Reinhold. II. Munker, Reinhold. Modern hematology. III. Series. [DNLM: 1. Hematologic Diseases. 2. Hematologic Neoplasms. WH 120 M689 2006] RC633.M866 2006 616.1'5--dc22 2006015501

FOREWORD Technological advances have quickly propelled hematology forward; for example: microarray expression analyses; single-nucleotide polymorphism (SNP) chips (platforms to look at genomic changes); sophisticated fluorescent in situ hybridization; newly identified cell surface antigens associated with various diseases and cell types; understanding of transcription factors (engines of proliferation and differentiation of hematopoietic cells); and more complete knowledge of chromosomal changes, mutations and amplifications associated with various hematological malignancies. These advances have been the engines for better diagnosis and classification of hematopoietic disorders. Furthermore, a variety of new therapeutic approaches have come to the forefront, such as targeted therapies (thyrosine kinase inhibitors) for myeloproliferative disorders; lenalidomide for myelodysplastic syndrome (MDS) and multiple myeloma; demethylating agents for MDS and myeloid leukemia, as well as, humanized monoclonal antibodies for lymphomas. Many of these advancements have occurred since the first edition of Modern Hematology: Biology and Clinical Management by Dr. Rienhold Munker and colleagues was published 6 years ago. This new edition, edited by Drs., Erhard Hiller, Jonathan Glass, and Ronald Paquette, provides in clear terms an understanding of the cellular physiology, immunology, and molecular biology of hematopoietic disorders. It gives new diagnostic methodologies and guides the health care worker to practical approaches to the diagnoses and management of these blood disorders. The book covers all of the major hematopoietic diseases and a number of the rare diseases as they interface with new scientific knowledge. It has excellent how to tables providing dosage and time schedules of different chemotherapeutic agents, as well as clearly defined tables to aid in diagnosis and prognosis. Modern Hematology: Biology and Clinical Management, Second Edition is a fine montage of applied research and practical approaches to diagnosis and management of our patients. The book is ideal for the house officers, fellows in training, interested scientists, as well as the practicing hematologist. H. Phillip Koeffler, MD v

PREFACE In the 6 years since the publication of Modern Hematology: Biology and Clinical Management, major advances in the understanding, diagnosis, and treatment of blood disorders have again been made. Molecular studies are now used on a daily basis to diagnose a variety of hematological disorders and to guide their treatment. Targeted therapies, such as kinase inhibitors in myeloproliferative disorders and humanized monoclonal antibodies for lymphomas, have transformed the treatment approach to these diseases. Peripheral blood and even umbilical cord blood are now routinely used as sources of stem cells for transplantation. The growing use of nonmyeloablative transplantation emphasizes immunotherapy over cytotoxic chemotherapy. These advances motivated us to update Modern Hematology: Biology and Clinical Management with the latest clinical and scientific developments in hematology. We welcome the contributions of new authors. The growing use of databases prompted us to add an overview of printed and electronic resources for hematologists. Modern Hematology: Biology and Clinical Management, Second Edition brings together facts, concepts, and protocols important for the practice of hematology. In 23 concise chapters, all major blood diseases are covered; rarer diseases are discussed if they are of scientific interest. The first two chapters introduce the reader to the scientific basis of blood disorders. As in the previous edition, each chapter is illustrated by tables, figures, and a selection of color plates. Our text is ideal for residents or fellows in training. However, students, physicians in other specialties, and even pure scientists may take advantage of our book both as a reference and a study guide. We hope that ultimately, all patients with benign and malignant blood disorders will benefit from the publication of Modern Hematology: Biology and Clinical Management, Second Edition., MD Erhard Hiller, MD Jonathan Glass, MD Ronald Paquette, MD vii

CONTENTS Foreword... v Preface... vii Contributors...xi Color Plates... xiii 1 Basic Biology of Hemopoiesis... 1 2 Molecular Biology and Cytokines... 19 and Amanda Sun 3 Supportive Care in Hematology... 41 John Hiemenz and 4 Transplantation of Stem Cells From Bone Marrow, Peripheral Blood, and the Umbilical Cord... 63 Ronald Paquette and 5 Anemias: General Considerations and Microcytic, and Megaloblastic Anemias... 83 6 Hemolytic Anemias...101, Ali Mansouri, Snehalata C. Gupte, and Vishwas Sakhalkar 7 Leukocytosis, Leukopenia, and Other Reactive Changes of Myelopoiesis...127 8 The Myeloproliferative Syndromes...137 Ronald Paquette, Erhard Hiller, and 9 Acute Myelogenous Leukemias...155 10 Acute Lymphoblastic Leukemias...173 and Vishwas Sakhalkar 11 Myelodysplastic Syndromes...195 Ronald Paquette and 12 Aplastic Anemias...207 Ronald Paquette and ix

x Contents 13 Lymphocytosis, Lymphocytopenia, Lymphadenopathy, and Splenomegaly...217 14 Hodgkin s Lymphoma...225 Erhard Hiller and 15 The Non-Hodgkin s Lymphomas...237, Jay Marion, Gang Ye, and Martin H. Dreyling 16 Multiple Myeloma and Related Paraproteinemias...271 Jonathan Glass and 17 Congenital and Acquired Immunodeficiencies...295 Vishwas Sakhalkar and 18 Infections Relevant to Hematology...315 19 Basic Principles of Hemostasis...327 Erhard Hiller 20 Bleeding Disorders...347 Erhard Hiller 21 Thrombophilia, Thromboembolic Disease, and Antithrombotic Therapy...381 Erhard Hiller 22 Transfusion Medicine and Immunohematology...401 Grace C. Tenorio, Snehalata C. Gupte, and 23 Storage Disorders in Hematology...433 APPENDICES 1 Glossary of Cytostatic Drugs and Targeted Therapies...441 2 CD Nomenclature for Human Leukocyte Antigens...455 3 Laboratory Values...463 4 Program Requirements for Residency and Fellowship Education in Hematology...465 5 Databases in Hematology...467 Index...475

CONTRIBUTORS MICHAEL COCKERHAM, PharmD Associate Professor of Clinical Pharmacy, Louisiana State University, Shreveport, LA MARTIN H. DREYLING, MD Associate Professor of Medicine, Ludwigs- Maximilians Universität, Munich, Germany JONATHAN GLASS, MD Professor of Medicine and Chief, Feist Weiller Cancer Center, Louisiana State University, Shreveport, LA SNEHALATA C. GUPTE, PhD Director, Surat Blood Transfusion Center, Surat, India JOHN HIEMENZ, MD Professor of Medicine, Louisiana State University, Shreveport, LA ERHARD HILLER, MD Professor of Medicine, Ludwigs-Maximilians Universität, Munich, Germany H. PHILLIP KOEFFLER, MD Division of Hematology/Oncology, Cedars Sinai Medical Center, Los Angeles, CA ALI MANSOURI, MD Professor of Medicine, Louisiana State University and Chief, Division of Hematology/Oncology, VA Medical Center, Shreveport, LA JAY MARION, MD Associate Professor of Medicine, Louisiana State University, Shreveport, LA REINHOLD MUNKER, MD Associate Professor of Medicine, Louisiana State University, Shreveport, LA RONALD PAQUETTE, MD Associate Professor of Medicine, University of California Los Angeles, Los Angeles, CA VISHWAS SAKHALKAR, MD Assistant Professor of Pediatrics, Louisiana State University, Shreveport, LA AMANDA SUN, MD, PhD Assistant Professor of Medicine, Louisiana State University, Shreveport, LA GRACE C. TENORIO, MD Assistant Professor of Pathology, Louisiana State University, Shreveport, LA GANG YE, MD Louisiana State University, Shreveport, LA xi

COLOR PLATES Color plates 1 23 appear in an insert following p. 242. Plate 1 Fig. 5.2, Megaloblastic Erythroblasts; for full caption, see p. 94. Plate 2 Fig. 7.1, Granulocytes; for full caption, see p. 129. Plate 3 Fig. 7.2, Döhle Bodies; for full caption, see p. 129. Plate 4 Fig. 9.3, APL, Myeloid Blasts; for full caption, see p. 162. Plate 5 Fig. 9.4, Peroxidase Stain, AML Blasts; for full caption, see p. 162. Plate 6 Fig. 9.5, Fluorescent in situ Hybridization in APL; for full caption, see p. 163. Plate 7 Fig. 10.2, ALL Lymphoblast; for full caption, see p. 179. Plate 8 Fig. 10.3, Blasts of B-ALL; for full caption, see p. 179. Plate 9 Fig. 11.1, Dysplastic Changes in Erythropoiesis; for full caption, see p. 199. Plate 10 Fig. 11.2, Ringed Sideroblasts, MDS; for full caption, see p. 200. Plate 11 Fig. 12.1, Aplastic Anemia, Histology; for full caption, see p. 212. Plate 12 Fig. 12.2, Normal Bone Marrow, Histology; for full caption, see p. 212. Plate 13 Fig. 13.3, Howell Jolly Bodies; for full caption, see p. 222. Plate 14 Fig. 14.2, Lymph Node, Hodgkin s; for full caption, see p. 230. Plate 15 Fig. 15.1, Lymph Node, Non-Hodgkin s; for full caption, see p. 243. Plate 16 Fig. 15.2, Follicle Center Lymphoma; for full caption, see p. 249. Plate 17 Fig. 15.3, CLL Morphology; for full caption, see p. 254. Plate 18 Fig. 15.4, PLL Morphology; for full caption, see p. 257. Plate 19 Fig. 15.5, Adult T-Cell Leukemia, Lymphoma; for full caption, see p. 258. Plate 20 Fig. 15.6, Hairy Cell Leukemia; for full caption, see p. 262. Plate 21 Fig. 16.2, Multiple Myeloma, Dense Infiltrate of Neoplastic Plasma Cells; for full caption, see p. 280. Plate 22 Fig. 16.3, Multiple Myeloma, Bone Marrow; for full caption, see p. 280. Plate 23 Fig. 18.1, Infectious Mononucleosis; for full caption, see p. 317. xiii